Innova Captab CFO Gaurav Srivastava Resigns Effective from March 29

Shares of Innova Captab experienced a decline of 2.91% following the announcement of the resignation of its Chief Financial Officer, Gaurav Srivastava, effective from March 29, 2024, citing personal reasons.

With Srivastava’s departure, he ceases to be the key managerial personnel (KMP) of the company as of the same date. The company clarified that the resignation was due to personal reasons, with no other material factors involved, as stated by the company.

Innova Captab, an integrated pharmaceutical company based in India, operates across the pharmaceutical value chain, encompassing research and development, manufacturing, drug distribution, marketing, and exports. The company’s operations span three main businesses: CDMO (contract development and manufacturing organization) services and products, domestic branded generics, and international branded generics.

Have you read?
Countries with the Highest Rates of Lung Cancer.
Countries with the highest rates of Dementia.
Countries with the Highest Rate of Diabetes.
Countries With the Most Car Accidents.
Countries with the Highest Teenage Pregnancy Rates.

This report/news/ranking/statistics has been prepared only for general guidance on matters of interest and does not constitute professional advice. You should not act upon the information contained in this publication without obtaining specific professional advice. No representation or warranty (express or implied) is given as to the accuracy or completeness of the information contained in this publication, and, to the extent permitted by law, CEOWORLD magazine does not accept or assume any liability, responsibility or duty of care for any consequences of you or anyone else acting, or refraining to act, in reliance on the information contained in this publication or for any decision based on it.

Email Address*

Name